The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $169.54

Today's change-0.30 -0.18%
Updated November 22 11:29 AM EST. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $169.54

Today's change-0.30 -0.18%
Updated November 22 11:29 AM EST. Delayed by at least 15 minutes.

Amgen Inc down (U.S.)$0.30

Amgen Inc is lower today, dropping (U.S.)$0.30 or 0.18% to (U.S.)$169.54. Over the last five days, shares are unchanged, but have gained 15.96% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $169.86
  • Previous close(U.S.) $169.84
  • High(U.S.) $170.73
  • Low(U.S.) $169.43
  • Bid / Ask(U.S.) $169.54 / (U.S.) $169.61
  • YTD % change+15.96%
  • Volume623,316
  • Average volume (10-day)2,362,458
  • Average volume (1-month)2,857,863
  • Average volume (3-month)2,605,619
  • 52-week range(U.S.) $138.83 to (U.S.) $191.10
  • Beta1.38
  • Trailing P/E15.31×
  • P/E 1 year forward13.41×
  • Forward PEG3.17×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.71%
  • Trailing EPS(U.S.) $11.07
Updated November 22 11:29 AM EST. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue5,7735,8105,4645,965
Total other revenue--------
Total revenue5,7735,8105,4645,965
Gross profit4,7834,7864,4684,898
Total cost of revenue9901,0249961,067
Total operating expense3,3343,1122,8733,480
Selling / general / administrative1,1701,2091,0641,323
Research & development8778737691,078
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----27-111
Other operating expenses, total297617123
Operating income2,4392,6982,5912,485
Interest income (expense), net non-operating-325-321-326-328
Gain (loss) on sale of assets--------
Other--------
Income before tax2,3812,5422,4602,283
Income after tax2,0212,1512,0711,935
Income tax, total360391389348
Net income2,0212,1512,0711,935
Total adjustments to net income--------
Net income before extra. items2,0212,1512,0711,935
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0212,1512,0711,935
Inc. avail. to common incl. extra. items2,0212,1512,0711,935
Diluted net income2,0212,1512,0711,935
Dilution adjustment--------
Diluted weighted average shares733738741742
Diluted EPS excluding extraordinary itemsvalue per share2.762.912.792.61
Dividends per sharevalue per share1.151.151.151.00
Diluted normalized EPSvalue per share2.762.912.832.48